BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Son MH, Ha LN, Bang MH, Bae S, Giang DT, Thinh NT, Paeng JC. Diagnostic and prognostic value of 99mTc-MAA SPECT/CT for treatment planning of 90Y-resin microsphere radioembolization for hepatocellular carcinoma: comparison with planar image. Sci Rep 2021;11:3207. [PMID: 33547398 DOI: 10.1038/s41598-021-82887-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 d’Abadie P, Walrand S, Lhommel R, Hesse M, Borbath I, Jamar F. Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Current Oncology 2022;29:2422-34. [DOI: 10.3390/curroncol29040196] [Reference Citation Analysis]
2 Luu MH, Walsum TV, Mai HS, Franklin D, Nguyen TTT, Le TM, Moelker A, Le VK, Vu DL, Le NH, Tran QL, Chu DT, Trung NL. Automatic scan range for dose-reduced multiphase CT imaging of the liver utilizing CNNs and Gaussian models. Med Image Anal 2022;78:102422. [PMID: 35339951 DOI: 10.1016/j.media.2022.102422] [Reference Citation Analysis]
3 Pandit-Taskar N, Iravani A, Lee D, Jacene H, Pryma D, Hope T, Saboury B, Capala J, Wahl RL. Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice. J Nucl Med 2021;62:60S-72S. [PMID: 34857623 DOI: 10.2967/jnumed.121.262977] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Alem Z, Murray TE, Egri C, Chung J, Liu D, Elsayes KM, Chang SD, Harris A. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:3596-614. [PMID: 33909092 DOI: 10.1007/s00261-021-03095-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]